Mimotope vaccine efficacy gets a "boost" from native tumor antigens

Por Buhrman, Jonathan D., Slansky, Jill E.
Publicado em 2013

Improving T cell responses to modified peptides in tumor vaccines

Por Buhrman, Jonathan D., Slansky, Jill E.
Publicado em 2013

Augmenting Anti-Tumor T Cell Responses to Mimotope Vaccination by Boosting with Native Tumor Antigens

Por Buhrman, Jonathan D., Jordan, Kimberly R., U’Ren, Lance, Sprague, Jonathan, Kemmler, Charles B., Slansky, Jill E.
Publicado em 2012

Improving Antigenic Peptide Vaccines for Cancer Immunotherapy Using a Dominant Tumor-specific T Cell Receptor

Por Buhrman, Jonathan D., Jordan, Kimberly R., Munson, Daniel J., Moore, Brandon L., Kappler, John W., Slansky, Jill E.
Publicado em 2013

Molecular profile of tumor-specific CD8+ T cell hypofunction in a transplantable murine cancer model()

Por Waugh, Katherine A., Leach, Sonia M., Moore, Brandon L., Bruno, Tullia C., Buhrman, Jonathan D., Slansky, Jill E.
Publicado no J Immunol (2016)

TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines

Por Jordan, Kimberly R., Buhrman, Jonathan D., Sprague, Jonathan, Moore, Brandon L., Gao, Dexiang, Kappler, John W., Slansky, Jill E.
Publicado em 2012